{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:02:05Z","timestamp":1789736525989,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T00:00:00Z","timestamp":1263945600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2458-10-28","type":"journal-article","created":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T14:28:55Z","timestamp":1263997735000},"source":"Crossref","is-referenced-by-count":12,"title":["Referrals for positive tuberculin tests in new health care workers and students: a retrospective cohort study"],"prefix":"10.1186","volume":"10","author":[{"given":"Yining","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Schwartzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,20]]},"reference":[{"key":"1939_CR1","volume-title":"WHO Report","author":"World Health Organization","year":"2009","unstructured":"World Health Organization: Global tuberculosis control: epidemiology, strategy, financing. WHO Report. 2009, Geneva, Switzerland: WHO Press, on October 20, 2009, [ http:\/\/www.who.int\/tb\/publications\/global_report\/2009\/pdf\/full_report.pdf ] . WHO\/HTM\/TB\/2008.411"},{"key":"1939_CR2","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/S0140-6736(06)68384-0","volume":"367","author":"C Dye","year":"2006","unstructured":"Dye C: Global epidemiology of tuberculosis. Lancet. 2006, 367: 938-940. 10.1016\/S0140-6736(06)68384-0.","journal-title":"Lancet"},{"key":"1939_CR3","doi-asserted-by":"publisher","first-page":"e494","DOI":"10.1371\/journal.pmed.0030494","volume":"3","author":"R Joshi","year":"2006","unstructured":"Joshi R, Reingold AL, Menzies D, Pai M: Tuberculosis among health-care workers in low- and middle-income countries: a systematic review. PLoS Medicine. 2006, 3: e494-10.1371\/journal.pmed.0030494.","journal-title":"PLoS Medicine"},{"key":"1939_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1056\/NEJM199501123320206","volume":"332","author":"D Menzies","year":"1995","unstructured":"Menzies D, Fanning A, Yuan L, Fitzgerald M: Tuberculosis among health care workers. N Engl J Med. 1995, 332: 92-98. 10.1056\/NEJM199501123320206.","journal-title":"N Engl J Med"},{"key":"1939_CR5","volume-title":"Tuberculosis in Canada 2007-Pre-release","author":"Public Health Agency of Canada","year":"2008","unstructured":"Public Health Agency of Canada: Tuberculosis in Canada 2007-Pre-release. 2008, Ottawa, Canada: Minister of Public Works and Government Services Canada, [ http:\/\/www.phac-aspc.gc.ca\/publicat\/2008\/tbcanpre07\/pdf\/tbpre2007-eng.pdf ]"},{"key":"1939_CR6","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1164\/ajrccm.154.4.8887599","volume":"154","author":"K Schwartzman","year":"1996","unstructured":"Schwartzman K, Loo V, Pasztor J, Menzies D: Tuberculosis infection among health care workers in Montreal. Am J Respir Crit Care Med. 1996, 154: 1006-1012.","journal-title":"Am J Respir Crit Care Med"},{"key":"1939_CR7","doi-asserted-by":"publisher","first-page":"779","DOI":"10.7326\/0003-4819-133-10-200011210-00010","volume":"133","author":"D Menzies","year":"2000","unstructured":"Menzies D, Fanning A, Yuan L, FitzGerald JM: Hospital ventilation and risk for tuberculous infection in Canadian health care workers. Ann Intern Med. 2000, 133: 779-789.","journal-title":"Ann Intern Med"},{"key":"1939_CR8","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1164\/ajrccm.152.2.7633747","volume":"152","author":"DE Griffith","year":"1995","unstructured":"Griffith DE, Hardman JL, Zhang Y, Wallace RJ, Mazurek GH: Tuberculosis outbreak among health care workers in a community hospital. Am J Respir Crit Care Med. 1995, 152: 808-811.","journal-title":"Am J Respir Crit Care Med"},{"key":"1939_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1056\/NEJMp068015","volume":"355","author":"TR Sterling","year":"2006","unstructured":"Sterling TR, Haas DW: Transmission of Mycobacterium tuberculosis from health care workers. N Engl J Med. 2006, 355: 118-121. 10.1056\/NEJMp068015.","journal-title":"N Engl J Med"},{"key":"1939_CR10","first-page":"1","volume-title":"Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005","author":"Centers for Disease Control and Prevention","year":"2005","unstructured":"Centers for Disease Control and Prevention: Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. 2005, CDC MMWR, 54 (No. RR-17): 1-140."},{"key":"1939_CR11","volume-title":"Canadian tuberculosis standards","year":"2007","unstructured":"Long R, ed: Canadian tuberculosis standards. 2007, Ottawa, Canada: Health Canada, Accessed on-line October 14, 2009, [ http:\/\/www.phac-aspc.gc.ca\/tbpc-latb\/pubs\/pdf\/tbstand07_e.pdf ]6","edition":"6"},{"key":"1939_CR12","first-page":"5221","volume":"161","author":"American Thoracic Society\/Centers for Disease Control and Prevention","year":"2000","unstructured":"American Thoracic Society\/Centers for Disease Control and Prevention: Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med. 2000, 161: 5221-5247.","journal-title":"Am J Respir Crit Care Med"},{"key":"1939_CR13","first-page":"733","volume-title":"Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and Revisions in American Thoracic Society\/CDC Recommendations--United States, 2001","author":"American Thoracic Society\/Centers for Disease Control and Prevention","year":"2001","unstructured":"American Thoracic Society\/Centers for Disease Control and Prevention: Update: Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and Revisions in American Thoracic Society\/CDC Recommendations--United States, 2001. 2001, CDC MMWR, 50 (34): 733-735."},{"key":"1939_CR14","doi-asserted-by":"publisher","first-page":"689","DOI":"10.7326\/0003-4819-149-10-200811180-00003","volume":"149","author":"D Menzies","year":"2008","unstructured":"Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, Memish Z, Khan K, Gardam M, Hoeppner V, Benedetti A, Schwartzman K: Adverse events with 4 months rifampin or 9 months isoniazid as therapy for latent TB infection: results of a randomized trial. Ann Intern Med. 2008, 149: 689-697.","journal-title":"Ann Intern Med"},{"key":"1939_CR15","first-page":"S98","volume":"2","author":"D Menzies","year":"1998","unstructured":"Menzies D, Fanning A, Yuan L, Mark FitzGerald J, Canadian Collaborative Group in Nosocomial Transmission of Tuberculosis: Tuberculosis in health care workers: a multicentre Canadian prevalence survey: preliminary results. Int J Tuberc Lung Dis. 1998, 2: S98-S102.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1939_CR16","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1164\/ajrccm\/145.3.621","volume":"145","author":"R Menzies","year":"1992","unstructured":"Menzies R, Vissandjee B: Effect of Bacille Calmette-Guerin vaccination on tuberculin reactivity. Am Rev Respir Dis. 1992, 145: 621-645.","journal-title":"Am Rev Respir Dis"},{"key":"1939_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1164\/ajrccm.159.1.9801120","volume":"159","author":"D Menzies","year":"1999","unstructured":"Menzies D: Interpretation of repeated tuberculin tests: Boosting, conversion and reversion. Am J Respir Crit Care Med. 1999, 159: 15-21.","journal-title":"Am J Respir Crit Care Med"},{"key":"1939_CR18","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1378\/chest.122.5.1609","volume":"122","author":"SJ Shukla","year":"2002","unstructured":"Shukla SJ, Warren DK, Woeltje KF, Gruber CA, Fraser VJ: Factors associated with the treatment of latent tuberculosis infection among health-care workers at a Midwestern teaching hospital. Chest. 2002, 122: 1609-1614. 10.1378\/chest.122.5.1609.","journal-title":"Chest"},{"key":"1939_CR19","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1086\/502343","volume":"25","author":"SR Salpeter","year":"2004","unstructured":"Salpeter SR, Salpeter EE: Screening and treatment of latent tuberculosis among healthcare workers at low, moderate, and high risk for tuberculosis exposure: a cost-effectiveness analysis. Infect Control Hosp Epidemiol. 2004, 25: 1056-1061. 10.1086\/502343.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1939_CR20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1086\/422995","volume":"39","author":"AS Gershon","year":"2004","unstructured":"Gershon AS, McGeer A, Bayoumi AM, Raboud J, Yang J: Health care workers and the initiation of treatment for latent tuberculosis infection. Clin Infect Dis. 2004, 39: 667-672. 10.1086\/422995.","journal-title":"Clin Infect Dis"},{"key":"1939_CR21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1086\/502142","volume":"24","author":"L Lambert","year":"2003","unstructured":"Lambert L, Rajbhandary S, Quails N, Budnick L, Catanzaro A, Cook S, Daniels-Cuevas L, Garber E, Reves R: Costs of implementing and maintaining a tuberculin skin test program in hospitals and health departments. Infect Control Hosp Epidemiol. 2003, 24: 814-820. 10.1086\/502142.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1939_CR22","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1001\/jama.1996.03530370051030","volume":"275","author":"BC Camins","year":"1996","unstructured":"Camins BC, Bock N, Watkins DL, Blumberg HM: Acceptance of isoniazid preventive therapy by health care workers after tuberculin skin test conversion. JAMA. 1996, 275: 1013-1015. 10.1001\/jama.275.13.1013.","journal-title":"JAMA"},{"key":"1939_CR23","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1378\/chest.113.5.1184","volume":"113","author":"PA LoBue","year":"1998","unstructured":"LoBue PA, Catanzaro A: Effectiveness of a nosocomial tuberculosis control program at an urban teaching hospital. Chest. 1998, 113: 1184-1189. 10.1378\/chest.113.5.1184.","journal-title":"Chest"},{"key":"1939_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2307\/30145538","volume":"15","author":"VJ Fraser","year":"1994","unstructured":"Fraser VJ, Kilo CM, Bailey TC, Medoff G, Dunagan WC: Screening of physicians for tuberculosis. Infect Control Hosp Epidemiol. 1994, 15: 95-100. 10.1086\/646868.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1939_CR25","volume-title":"Ending neglect: the elimination of tuberculosis in the United States","author":"Committee on the elimination of tuberculosis in the United States, Division of health promotion and disease prevention, Institute of Medicine","year":"2000","unstructured":"Committee on the elimination of tuberculosis in the United States, Division of health promotion and disease prevention, Institute of Medicine: Ending neglect: the elimination of tuberculosis in the United States. 2000, Washington: National Academy Press"},{"key":"1939_CR26","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1164\/ajrccm.162.6.2001111","volume":"162","author":"K Dasgupta","year":"2001","unstructured":"Dasgupta K, Schwartzman K, Marchand R, Tannenbaum TN, Brassard P, Menzies D: Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. Am J Respir Crit Care Med. 2001, 162: 2079-2086.","journal-title":"Am J Respir Crit Care Med"},{"key":"1939_CR27","first-page":"16","volume":"11","author":"O Oxlade","year":"2007","unstructured":"Oxlade O, Schwartzman K, Menzies D: Interferon-gamma release assays and TB screening in high-income countries: A cost-effectiveness analysis. Int J Tuberc Lung Dis. 2007, 11: 16-26.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1939_CR28","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1164\/ajrccm.161.3.9902005","volume":"161","author":"K Schwartzman","year":"2000","unstructured":"Schwartzman K, Menzies D: Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis. Am J Respir Crit Care Med. 2000, 161: 780-789.","journal-title":"Am J Respir Crit Care Med"},{"key":"1939_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1086\/593965","volume":"30","author":"R Sahni","year":"2009","unstructured":"Sahni R, Miranda C, Yen-Lieberman B, Tomford JW, Terpeluk P, Quartey P, Johnson LT, Gordon SM: Does the implementation of an Interferon-\u03b3 release assay in lieu of a tuberculin skin test increase acceptance of preventive therapy for latent tuberculosis among healthcare workers?. Infect Control Hosp Epidemiol. 2009, 30: 197-199. 10.1086\/593965.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1939_CR30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1183\/09031936.00145906","volume":"30","author":"R Diel","year":"2007","unstructured":"Diel R, Wrighton-Smith P, Zellweger J-P: Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis. Eur Respir J. 2007, 30: 321-332. 10.1183\/09031936.00145906.","journal-title":"Eur Respir J"},{"key":"1939_CR31","first-page":"ACS-6","volume":"34","author":"Canadian Tuberculosis Committee, Public Health Agency of Canada","year":"2008","unstructured":"Canadian Tuberculosis Committee, Public Health Agency of Canada: An Advisory Committee Statement: Updated recommendations on interferon-gamma release assays for latent tuberculosis infection. Canada Communicable Disease Report. 2008, 34: ACS-6-[ http:\/\/www.phac-aspc.gc.ca\/publicat\/ccdr-rmtc\/08pdf\/acs-6.pdf ]","journal-title":"An Advisory Committee Statement: Updated recommendations on interferon-gamma release assays for latent tuberculosis infection. Canada Communicable Disease Report"},{"key":"1939_CR32","volume-title":"Tuberculosis: clinical diagnosis and management of tuberculosis, and guidelines for its prevention and control","author":"National Health Service National Institute for Health and Clinical Excellence","year":"2006","unstructured":"National Health Service National Institute for Health and Clinical Excellence: Clinical Guideline 33. Tuberculosis: clinical diagnosis and management of tuberculosis, and guidelines for its prevention and control. 2006, Accessed October 20, 2009, [ http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG033niceguideline.pdf ]"},{"key":"1939_CR33","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/0003-4819-149-11-200812020-00248","volume":"149","author":"M Bakir","year":"2008","unstructured":"Bakir M, Millington KA, Soysal A, Deeks JJ, Efee S, Aslan Y, Dosanjh DPS, Lalvani A: Prognostic value of a T-cell based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med. 2008, 149: 777-786.","journal-title":"Ann Intern Med"},{"key":"1939_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1164\/rccm.200811-1704OC","volume":"180","author":"RN van Zyl-Smit","year":"2009","unstructured":"van Zyl-Smit RN, Pai M, Peprah K, Meldau R, Kieck J, Juritz J, Badri M, Zumla A, Sechi LA, Bateman ED, Dheda K: Within-subject variability and boosting of T-cell Interferon- y responses after tuberculin skin testing. Am J Respir Crit Care Med. 2009, 180: 49-58. 10.1164\/rccm.200811-1704OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1939_CR35","doi-asserted-by":"publisher","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","volume":"146","author":"D Menzies","year":"2007","unstructured":"Menzies D, Pai M, Comstock G: Meta-analysis: New tests for the diagnosis of latent tuberculosis infection: Areas of uncertainty and recommendations for research. Ann Intern Med. 2007, 146: 340-354.","journal-title":"Ann Intern Med"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-10-28.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-10-28\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-10-28","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T15:10:16Z","timestamp":1468509016000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-10-28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,20]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["1939"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-10-28","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,20]]},"article-number":"28"}}